ABBV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
AbbVie Inc's other long-term assets for the quarter that ended in Sep. 2014 was $925 Mil.
AbbVie Inc's quarterly other long-term assets increased from Mar. 2014 ($922 Mil) to Jun. 2014 ($925 Mil) but then stayed the same from Jun. 2014 ($925 Mil) to Sep. 2014 ($925 Mil).
AbbVie Inc's annual other long-term assets declined from Dec. 2011 ($1,149 Mil) to Dec. 2012 ($954 Mil) and declined from Dec. 2012 ($954 Mil) to Dec. 2013 ($885 Mil).
Assets are presented on the balance sheet in order of their liquidity. If a company expects to sell or otherwise recognize the economic value of an asset within one year, the asset is generally classified as a current asset on the balance sheet. Cash on hand is a common current asset.
A long-term asset is an asset that a company expects to sell or otherwise recognize the economic value of after more than one year. Property, plant and equipment, and intangible assets are common long-term assets. Except those two items and current assets, the others we treated as "Other Long Term Assets".
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
AbbVie Inc Annual Data
|Other Long-Term Assets||0||0||0||0||0||0||0||1,149||954||885|
AbbVie Inc Quarterly Data
|Other Long-Term Assets||1,111||1,137||954||1,833||1,814||1,273||885||922||925||925|